Locations
England, UK · London, UK · Mile End, London, UK · Kingston Vale, London SW15, UK
industry
Artificial Intelligence · Biology · Biotech · Biotechnology · Biotechnology Research · Discovery Tools (Healthcare) · Drug Discovery · Health Care · Machine Learning · Medical · Pharmaceuticals · Science and Engineering · Therapeutics
Size
11 - 50 employees
Stage
Other
founded in
2019
Micrographia Bio is a developer of a drug discovery platform. They are designed to accelerate biomedical innovation and eradicate the commercial barrier to developing new medicines via artificial intelligence-enabled bioimage analysis. They focus on the autonomous assessment of the therapeutic mechanism of action as well as combining novel methods for multiplexed microscopy imaging with machine-intelligent computer vision software to understand the true nature of the therapeutic activity, enabling healthcare professionals to resolve the true molecular functions of potential therapeutics.
Something looks off?